TMC
NRX

Trellus Management Company’s NEPHROGENEX INC COM NRX Stock Holding History

Trellus Management Company’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$81K – 145
2014
Q1 		$81K Buy
+10,000
New +$102K 0.07% 111

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FWCM
First Western Capital Management Los Angeles, California $4.71M AUM 11.17% 1-Year Est. Return
RCMB
Revelation Capital Management (Bermuda) Hamilton, Bermuda $1.14M AUM 18.96% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Trellus Management Company's NRX Position: Q2 2014 in Review

Trellus Management Company sold out of NEPHROGENEX INC COM (NRX) in Q2 2014, closing a stake of 10,000 shares — an estimated $81K sold.

Trellus Management Company first reported a position in NRX in Q1 2014 and held it in 1 quarter. The position peaked at $81K in Q1 2014. 11 funds tracked by Wall St. Rank hold NRX as of Q2 2014.

  • Trellus Management Company reported no remaining NEPHROGENEX INC COM position as of Q2 2014 after selling out during the quarter.
  • Trellus Management Company sold 10,000 NEPHROGENEX INC COM shares in Q2 2014, an estimated $81K.
  • Trellus Management Company first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 1 quarter.
  • Trellus Management Company's NEPHROGENEX INC COM position peaked at $81K in Q1 2014.
  • 11 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2014.

Based on Trellus Management Company's 13F filing for Q2 2014, filed 14 Aug 2014.